Identifies themes and clusters of stock movements
Market TodayThemes and Stocks SummaryThematic Stock SearchClick here for daily refresh schedule
PMD - Psychemedics Corp.
$5.34
0.39(7.88%)9:00:00 PM 1/19/2021
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, opiates, synthetic cannabinoids, and benzodiazepines. Its testing results provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data that can show a pattern of individual drug use over a longer period-of-time. The company provides its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was founded in 1986 and is headquartered in Acton, Massachusetts.
Stock Chart

Summary:

  • Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics
leak data

Related Topics

Peers

Stock news

    01/2/2021PMD
    Trade Alert: Peter Kamin At Psychemedics Corporation (NASDAQ:PMD), Has Just Spent US$258k Buying 44% More Shares

    Potential Psychemedics Corporation ( NASDAQ:PMD ) shareholders may wish to note that insider Peter Kamin recently...

    12/17/2020PMD
    Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel

    ACTON, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Sarah Ashby has rejoined the company as Vice President, General Counsel. In this important role, Sarah will be responsible for directing and managing all of the company’s legal activities. She will report directly to the company’s CEO.Sarah rejoins Psychemedics from Decibel Therapeutics, Inc., a biotech start-up researching hearing loss therapeutics, and Takeda Pharmaceutical Company, Ltd.  In ...

    11/29/2020PMD
    Where Do Hedge Funds Stand On Psychemedics Corp. (PMD)?

    In this article you are going to find out whether hedge funds think Psychemedics Corp. (NASDAQ:PMD) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among […]

    11/9/2020PMD
    Psychemedics Announces Third Quarter Results

    ACTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2020. The Company’s revenue for the quarter ended September 30, 2020 was $5.2 million versus $9.9 million for the quarter ended September 30, 2019, a decrease of 47%. Net loss for the quarter ended September 30, 2020 was $1.1 million or ($0.20) per diluted share, versus net income of $0.7 million or $0.12 per diluted share, for ...

    08/12/2020PMD
    Psychemedics Announces Second Quarter Results

    ACTON, Mass., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced second quarter financial results for the period ended June 30, 2020.  The Company’s revenue for the quarter ended June 30, 2020 was $3.3 million versus $9.3 million for the quarter ended June 30, 2019, a decrease of 64%.  Net loss for the quarter ended June 30, 2020 was $2.1 million or ($0.37) per diluted share, versus net income of $0.8 million or $0.14 per diluted share, for the comparable pe...

    08/12/2020PMD
    Returns On Capital Tell Us A Lot About Psychemedics (NASDAQ:PMD)

    If you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop...

    08/12/2020PMD
    We Think Psychemedics (NASDAQ:PMD) Can Stay On Top Of Its Debt

    Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

    05/28/2020PMD
    Hedge Funds Are Selling Psychemedics Corp. (PMD)

    At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […]